A combined effect of dextromethorphan and melatonin on neuropathic pain behavior in rats

Brain Research

Volumn 1288, Issue , 2009, Pages 42-49

  Wang, Shuxing ^a   Zhang, Lin ^a   Lim, Grewo ^a   Sung, Backil ^a   Tian, Yinghong ^a   Chou, Chiu Wen ^a   Hernstadt, Hayley ^a   Rusanescu, Gabriel ^a   Ma, Yuxin ^a   Mao, Jianren ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Depression; Dextromethorphan; Melatonin; Neuropathic pain

Indexed keywords

DEXTROMETHORPHAN; MELATONIN;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CINGULATE GYRUS; CONTROLLED STUDY; DEPRESSION; DRUG POTENTIATION; HYPERALGESIA; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MECHANICAL ALLODYNIA; MONOTHERAPY; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SWIMMING; THERMAL HYPERALGESIA; WISTAR KYOTO RAT;

ANALYSIS OF VARIANCE; ANIMALS; CHRONIC DISEASE; DEXTROMETHORPHAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HYPERALGESIA; INJECTIONS, INTRAPERITONEAL; MALE; MELATONIN; NEURALGIA; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, INBRED WKY; SCIATIC NERVE;

RATTUS; RATTUS NORVEGICUS;

EID: 69249229452     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.06.094     Document Type: Article

References (99)

1. Armario A., Gavalda A., and Marti J. Comparison of the behavioural and endocrine response to forced swimming stress in five inbred strains of rats. Psychoneuroendocrinology 20 (1995) 879-890
2. Arner S., and Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33 (1988) 11-23
3. Arnow B.A., Hunkeler E.M., Blasey C.M., Lee J., Constantino M.J., Fireman B., Kraemer H.C., Dea R Robinson R., and Hayward C. Comorbid depression, chronic pain, and disability in primary care. Psychosom. Med. 68 (2006) 262-268
4. Atkinson J.H., Slater M.A., Williams R.A., Zisook S., Patterson T.L., Grant I., Wahlgren D.R., Abramson I., and Garfin S.R. A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain 76 (1998) 287-296
5. Bair M.J., Robinson R.L., Katon W., and Kroenke K. Depression and pain comorbidity; a literature review. Arch. Intern. Med. 163 (2003) 2433-2445
6. Banks S., and Kerns R. Explaining high rates of depression in chronic pain. A diathesis-stress framework. Psychol. Bull. 119 (1996) 95-110
7. Beck-Friis J., Kjellman B.F., Aperia B., Unden F., von Rosen D., Ljunggren J.G., and Wetterberg L. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psychiatr. Scand. 71 (1985) 319-330
8. Ben Abraham R., Marouani N., and Weinbroum A.A. Dextromethorphan mitigates phantom pain in cancer amputees. Ann. Surg. Oncol. 10 (2003) 268-274
9. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
10. Brzezinski A. Melatonin in humans. N. Eng. J. Med. 336 (1997) 186-195
11. Carlsson K.C., Hoem N.O., Moberg E.R., and Mathisen L.C. Analgesic effect of dextromethorphan in neuropathic pain. Acta Anaesthesiol. Scand. 48 (2004) 236-328
12. Carter G.T. Antidepressants in pain management. Curr. Opin. Investig. Drugs 3 (2002) 454-458
13. Chang F.L., Wu C.T., Yeh C.C., Lin T.C., Ho S.T., and Wong C.S. Postoperative intramuscular dextromethorphan injection provides postoperative pain relief and decreases opioid requirement after hemorrhoidectomy. Acta Anaesthesiol. Sin. 37 (1999) 179-183
14. Citera G., Arias M.A., Maldonado-Cocco J.A., Lazaro M.A., Rosemffet M.G., Brusco L.I., Scheines E.J., and Cardinalli D.P. The effect of melatonin in patients with fibromyalgia: a pilot study. Clin. Rheumatol. 19 (2000) 9-13
15. Cohen S.P., Chang A.S., Larkin T., and Mao J. The intravenous ketamine test: a predictive response tool for oral dextromethorphan treatment in neuropathic pain. Anesth. Analg. 99 (2004) 1753-1759 table of contents
16. Cohen S.P., Verdolin M.H., Chang A.S., Kurihara C., Morlando B.J., and Mao J. The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients. J. Pain 7 (2006) 391-398
17. Collins S.L., Moore R.A., McQuay H.J., and Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J. Pain Symptom. Manage. 20 (2000) 449-458
18. De La Garza R., and Mahoney J.J. A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression. Brain Res. 1021 (2004) 209-218
19. Detke M.J., Rickels M., and Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 21 (1995) 66-72
20. Dubner R., and Hargreaves K.M. The neurobiology of pain and its modulation. Clin. J. Pain Suppl. 2 (1989) S1
21. Duedahl T.H., Rømsing J., Møiniche S., and Dahl J.B. A qualitative systematic review of peri-operative dextromethorphan in post-operative pain. Acta Anaesthesiol. Scand. 50 (2006) 1-13
22. Fazli-Tabaei S., Maghsoudi A., Bazaz N., Modirzadeh A., and Zarrindast M.R. Effect of dextromethorphan on antinociception and tolerance induced by swim-stress in the formalin test. Arch Iran Med. 11 (2008) 286-292
23. Ferrer-Garcia M.D., Wernicke J.F., Detke M.J., and Iyengar S. The depression-pain complex: overlap between the two problems and implications for neuropathic pain. In: Campbell J.N., Basbaum A.I., Dray A., Dubner R., Dworkin R.H., and Sang C.N. (Eds). Emerging Strategies for the Treatment of Neuropathic Pain (2006), IASP Press, Seattle 307-325
24. Frazer A., Brown R., Kocsis J., Caroff S., Amsterdam J., Winokur A., Sweeney J., and Stokes P. Patterns of melatonin rhythms in depression. J. Neural Transm. Suppl. 21 (1986) 269-290
25. Frymoyer A.R., Rowbotham M.C., and Petersen K.L. Placebo-controlled comparison of a morphine/dextromethorphan combination with morphine on experimental pain and hyperalgesia in healthy volunteers. J. Pain 8 (2007) 19-25
26. Galer B.S., Lee D., Ma T., Nagle B., and Schlagheck T.G. MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Pain 115 (2005) 284-295
27. Golombek D.A., Escolar E., Burin L.J., De Brito Sanchez M.G., and Cardinali D.P. Time-dependent melatonin analgesia in mice: inhibition by opiate or benzodiazepine antagonism. Eur. J. Pharmacol. 194 (1991) 25-30
28. Grisel J.E., Allen S., Nemmani K.V., Fee J.R., and Carliss R. The influence of dextromethorphan on morphine analgesia in Swiss Webster mice is sex-specific. Pharmacol. Biochem. Behav. 81 (2005) 131-138
29. Halbreich U., Weinberg U., Stewart J., Klein D.F., Weitzman E.D., and Quitkin F.M. An inverse correlation between serum levels of desmethylimipramine and melatonin-like immunoreactivity in DMI-responsive depressives. Psychiatry Res. 4 (1981) 109-113
30. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
31. Jackson K.C., and St Onge E.L. Antidepressant pharmacotherapy: considerations for the pain clinician. Pain Pract. 3 (2003) 135-143
32. Jadad A.R., Carroll D., Glynn C.J., Moore R.A., and McQuay H.J. Morphine responsiveness of chronic pain: double-blind randomized crossover study with patient-controlled analgesia. Lancet 339 (1992) 1367-1371
33. Kupers R.C., Konings H., Adriaensen H., and Gybels J.M. Morphine differentially affects the sensory and affective pain rating in neurogenic pain and idiopathic forms of pain. Pain 47 (1991) 5-12
34. Leino P., and Magni G. Depression and distress symptoms as predictors of low back pain, neck-shoulder pain, and other musculoskeletal morbidity: a 10 year follow-up of metal industry employees. Pain 53 (1993) 89-94
35. Leone M., D'Amico D., Moschiano F., Fraschini F., and Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia 16 (1996) 494-496
36. Leone M., Lucini V., D'Amico D., Moschiano F., Maltempo C., Fraschini F., and Bussone G. Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia 15 (1995) 224-229
37. Li S.R., Wang T., Wang R., Dai X., Chen Q., and Li R.D. Melatonin enhances antinociceptive effects of delta-, but not mu-opioid agonist in mice. Brain Res. 1043 (2005) 132-138
38. Littlejohn G.O., and Guymer E.K. Fibromyalgia syndrome: which antidepressant drug should we choose?. Curr. Pharm. Des. 12 (2006) 3-9
39. Lopez-Rubalcava C., and Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 22 (2000) 191-199
40. Lynch III J.J., Wade C.L., Zhong C.M., Mikusa J.P., and Honore P. Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model. Pain 110 (2004) 56-63
41. Magni G., Marchetti M., Moreschi C., Merskey H., and Luchini S.R. Chronic musculoskeletal pain and depression symptoms in the National Health and Nutrition Examination. I. Epidemiologic follow-up study. Pain 53 (1993) 163-168
42. Magni G., Moreschi C., Rigatti-Luchini S., and Merskey H. Prospective study on the relationship between depression symptoms and chronic musculoskeletal pain. Pain 56 (1994) 289-297
43. Magni G., Schifano F., and De Leo D. Pain as a symptom in elderly depressed patients. Eur. Arch. Psychiatry Neurol. Sci. 235 (1985) 143-145
44. Mao J., and Chen L.L. Gabapentin in pain management. Anesth. Analg. 91 (2000) 680-687
45. Mao J., and Chen L.L. Systemic lidocaine for neuropathic pain relief. Pain 87 (2000) 7-17
46. Mao J., Price D.D., and Mayer D.J. Mechanisms of hyperalgesia and opiate tolerance: a current view of their possible interactions. Pain 62 (1995) 259-274
47. Mao J., Price D.D., and Mayer D.J. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 61 (1995) 353-364
48. Mao J., Price D.D., Zhu J., Lu J., and Mayer D.J. The inhibition of nitric oxide-activated poly (ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat. Pain 72 (1997) 355-366
49. Max B., Kishore-Kumar R., Schafer S.C., Merster B., Gracely R.H., Smoller B., et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 45 (1991) 3-9
50. Max B., Lynch S.A., Muir J., Shoaf S.E., Smoller B., and Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N. Engl. J. Med. 326 (1992) 1250-1256
51. Max M.B. Treatment of post-herpetic neuralgia: antidepressants. Ann. Neurol. 35 (1994) S50-S53
52. Max M.B., Culnane M., and Schafer S.C. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37 (1987) 589-596
53. Mico J.A., Ardid D., Berrocoso E., and Eschalier A. Antidepressants and pain. Trends Pharmacol. Sci. 27 (2006) 348-354
54. Morgan P.J., Barrett P., Howell H.E., and Helliwell R. Melatonin receptor: localization, molecular pharmacology and physiological significance. Neurochem. Int. 24 (1994) 101-146
55. Okamoto K., and Aoli K. Development of a stroma of spontaneously hypertensive rats. Jpn. Circ. J. 27 (1963) 282-293
56. Olesen A.E., Staahl C., Ali Z., Drewes A.M., and Arendt-Nielsen L. Effects of paracetamol combined with dextromethorphan in human experimental muscle and skin pain. Basic Clin. Pharmacol. Toxicol. 101 (2007) 172-176
57. Onal S.A., Inalkac S., Kutlu S., and Kelestimur H. Intrathecal melatonin increases the mechanical nociceptive threshold in the rat. Agri 16 (2004) 35-40
58. Ossipov M.H., Lopez Y., Nichols M.L., Bian D., and Porreca F. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci. Lett. 199 (1995) 87-90
59. Overstreet D.H., Friedman E., Mathe A.A., and Yadid G. The Flinders sensitive line rat: a selectively bred putative animal model of depression. Neurosci. Biobehav. Rev. 29 (2005) 739-759
60. Overstreet D.H., Pucilowski O., Retton M.C., Delagrange P., and Guardiola-Lemaitre B. Effects of melatonin receptor ligands on swim test immobility. Neuroreport 9 (1998) 249-253
61. Pandi-Perumal S.R., Srinivasan V., Maestroni G.J.M., Cardinali D.P., Poeggeler B., and Hardeland R. Melatonin: nature's most versatile biological signal?. FEBS J. 273 (2006) 2813-2838
62. Pang C.S., Tsang S.F., and Yang J.C. Effects of melatonin, morphine and diazepam on formalin-induced nociception in mice. Life Sci. 68 (2001) 943-951
63. Pare W.P. Enhanced retrieval of unpleasant memories influenced by shock controllability, shock sequence and rat strain. Biol. Psychiatry 39 (1996) 808-813
64. Pare W.P. Open field, learned helplessness, defensive burying, and forced-swim tests in WKY rats. Physiol. Behav. 55 (1994) 433-439
65. Pare W.P. Passive-avoidance behavior in Wistar-Kyoto (WKY), Wistar and Fischer-344 rats. Physiol. Behav. 54 (1993) 845-852
66. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioral despair in rats: a new model sensitive to antidepressant treatment. Eur. J. Pharmacol. 47 (1978) 379-391
67. Porsolt R.D., Bertin A., and Jalfre M. 'Behavioral despair' in rats and mice: strain differences and the effects of imipramine. Eur. J. Pharmacol. 51 (1978) 291-294
68. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
69. Raghavendra V., Agrewala J.N., and Kulkarni S.K. Melatonin reversal of lipopolysaccharides-induced thermal and behavioral hyperalgesia in mice. Eur. J. Pharmacol. 395 (2000) 15-21
70. Raghavendra V., and Kulkarni S.K. Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice. Eur. J. Pharmacol. 409 (2000) 279-289
71. Redwine K.E., and Trujillo K.A. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat. Pharmacol. Biochem. Behav. 76 (2003) 361-372
72. Sawynok J., and Reid A. Modulation of formalin-induced behaviors and edema by local and systemic administration of dextromethorphan, memantine and ketamine. Eur. J. Pharmacol. 450 (2002) 153-162
73. Sawynok J., and Reid A. Peripheral interactions between dextromethorphan, ketamine and amitriptyline on ormalin-evoked behaviors and paw edema in rats. Pain 102 (2003) 179-186
74. Sharav Y., Singer E., Schmidt E., Dionne R.A., and Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain 31 (1987) 199-209
75. Shavali S., Ho B., Govitrapong P., Sawlom S., Ajjimaporn A., Klongpanichapak S., and Ebadi M. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Res. Bull. 64 (2005) 471-479
76. Sindrup S.H., and Jensen T.S. Efficacy of pharmacological treatment of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83 (1999) 389-900
77. Siu A., and Drachtman R. Dextromethorphan: a review of N-methyl-d-aspartate receptor antagonist in the management of pain. CNS Drug Rev. 13 (2007) 96-106
78. Song G.H., Leng P.H., Gwee K.A., Moochhala S.M., and Ho K.Y. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. Gut 54 (2005) 1402-1407
79. Stankov B., Cozzi B., Lucini V., Capsoni S., Fauteck J., Fumagalli P., and Fraschini F. Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding. Neurosci. Lett. 133 (1991) 68-72
80. Staud R., Vierck C.J., Robinson M.E., and Price D.D. Effects of the N-methyl-d-aspartate receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects. J. Pain 6 (2005) 323-332
81. Sugden D. Psychopharmacological effects of melatonin in mouse and rat. J. Pharmacol. Exp. Ther. 227 (1983) 587-591
82. Sullivan M.J., Reesor K., Mikail S., and Fisher R. The treatment of depression in chronic low back pain: review and recommendations. Pain 50 (1992) 5-13
83. Tal M., and Bennett G.J. Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve. Pain 57 (1994) 375-382
84. Thomas P.K. Clinical features and differential diagnosis of peripheral neuropathy. In: Dyck P.J., Thomas P.K., Lambert E.H., and Bunge R. (Eds). Peripheral Neuropathy (1984), W.B. Saunders Company, Philadelphia 1169-1190
85. Tu Y., Sun R.Q., and Willis W.D. Effects of intrathecal injections of melatonin analogs on capsaicin-induced secondary mechanical allodynia and hyperalgesia in rats. Pain 109 (2004) 340-350
86. Vanecek J. Cellular mechanisms of melatonin action. Physiol. Rev. 78 (1998) 687-721
87. Vitte P.A., Harthe C., Pevet P., and Claustrat B. Brain autoradiographic study in the golden hamster after intracarotid injection of [14C]melatonin. Neurosci. Lett. 110 (1990) 1-5
88. Von Gall C., Stehle J.H., and Weaver D.R. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res. 309 (2002) 151-162
89. Von Knorring L., Perris C., Eisemann M., Erisksson U., and Perris H. Pain as a symptom in depressive disorders. I. Relationship to diagnostic subgroup and depressive symptomatology. Pain 15 (1983) 19-26
90. Waldenlind E., Gustafsson S.A., Ekbom K., and Wetterberg L. Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission. J. Neurol. Neurosurg. Psychiatry 50 (1987) 207-213
91. Watson C.P.N., Evans R.J., Reed K., Merskey H., Goldsmith L., and Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 32 (1982) 671-673
92. Wegert S., Ossipov M.H., Nichols M.L., Bian D., Vanderah T.W., Malan Jr. T.P., and Porreca F. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal and nerve-injured rats. Pain 71 (1997) 57-64
93. Weil Z.M., Hotchkiss A.K., Gatien M.L., Pieke-Dahl S., and Nelson R.J. Melatonin receptor (MT1) knockout mice display depression-like behaviors and deficits in sensorimotor gating. Brain Res. Bull. 68 (2006) 425-429
94. Wetterberg L. Melatonin and affective disorders. Ciba Found Symp. 17 (1985) 253-265
95. Woolf C.J., and Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353 (1999) 1959-1964
96. Yu C.X., Zhu C.B., Xu S.F., Cao X.D., and Wu G.C. Selective MT (2) melatonin receptor antagonist blocks melatonin-induced antinociception in rats. Neurosci. Lett. 24 (2000) 161-164
97. Yu C.X., Zhu C.B., Xu S.F., Cao X.D., and Wu G.C. The analgesic effects of peripheral and central administration of melatonin in rats. Eur. J. Pharmacol. l (2000) 49-53
98. Zahn P.K., Lansmann T., Berger E., Speckmann E.J., and Musshoff U. Gene expression and functional characterization of melatonin receptors in the spinal cord of the rat: implications for pain modulation. J. Pineal. Res. 35 (2003) 24-31
99. Zeng Q., Wang S., Lim G., Yang L., Mao J., Sung B., Chang Y., Lim J.A., Guo G., and Mao J. Exacerbated mechanical allodynia in rats with depression-like behavior. Brain Res. 1200 (2008) 27-38